4.8 Article

Performance comparison of whole-genome sequencing platforms

Journal

NATURE BIOTECHNOLOGY
Volume 30, Issue 1, Pages 78-U118

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2065

Keywords

-

Funding

  1. Stanford Department of Genetics
  2. US National Institutes of Health
  3. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357, R01HG006137, RC2HG005570] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Whole-genome sequencing is becoming commonplace, but the accuracy and completeness of variant calling by the most widely used platforms from Illumina and Complete Genomics have not been reported. Here we sequenced the genome of an individual with both technologies to a high average coverage of similar to 76x, and compared their performance with respect to sequence coverage and calling of single-nucleotide variants (SNVs), insertions and deletions (indels). Although 88.1% of the similar to 3.7 million unique SNVs were concordant between platforms, there were tens of thousands of platform-specific calls located in genes and other genomic regions. In contrast, 26.5% of indels were concordant between platforms. Target enrichment validated 92.7% of the concordant SNVs, whereas validation by genotyping array revealed a sensitivity of 99.3%. The validation experiments also suggested that >60% of the platform-specific variants were indeed present in the genome. Our results have important implications for understanding the accuracy and completeness of the genome sequencing platforms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available